| scholarly article | Q13442814 |
| P50 | author | Cory M Hogaboam | Q61079289 |
| Fernando J Martinez | Q89536935 | ||
| P2093 | author name string | William D Travis | |
| Raj K Puri | |||
| Kevin R Flaherty | |||
| Galen B Toews | |||
| Thomas V Colby | |||
| Bharat H Joshi | |||
| Steven L Kunkel | |||
| Holly Evanoff | |||
| Kristin J Carpenter | |||
| Claudia Jakubzick | |||
| Esther S Choi | |||
| P2860 | cites work | The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1 | Q24310131 |
| Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains | Q24310724 | ||
| Growth factors in idiopathic pulmonary fibrosis: relative roles | Q24798972 | ||
| A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma | Q28215226 | ||
| Interstitial fibrosis and growth factors | Q28391906 | ||
| Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system | Q33820954 | ||
| Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification | Q34066372 | ||
| ??? | Q28215495 | ||
| Interleukin-4 and interleukin-13: their similarities and discrepancies | Q34488885 | ||
| Idiopathic pulmonary fibrosis: new insights in its pathogenesis | Q34962398 | ||
| Re-evaluation of fibrogenic cytokines in lung fibrosis | Q35060877 | ||
| Impact of interleukin-13 responsiveness on the synthetic and proliferative properties of Th1- and Th2-type pulmonary granuloma fibroblasts | Q35749147 | ||
| Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition | Q35786037 | ||
| Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. | Q39804205 | ||
| Fibroblast chemotaxis induction by human recombinant interleukin-4. Identification by synthetic peptide analysis of two chemotactic domains residing in amino acid sequences 70-88 and 89-122. | Q40348725 | ||
| TNF-alpha and IL-4 regulate expression of IL-13 receptor alpha2 on human fibroblasts | Q40611159 | ||
| A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis | Q40631272 | ||
| Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells | Q40748434 | ||
| Idiopathic pulmonary fibrosis: current concepts | Q40835350 | ||
| Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production | Q40849898 | ||
| Pulmonary fibrosis: cytokines in the balance | Q40852034 | ||
| Two different IL-13 receptor chains are expressed in normal human skin fibroblasts, and IL-4 and IL-13 mediate signal transduction through a common pathway | Q41011905 | ||
| Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung | Q41068693 | ||
| Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells | Q41090719 | ||
| Effects of Th1 and Th2 cytokines on cytokine production and ICAM-1 expression on synovial fibroblasts | Q41468042 | ||
| Cell-to-cell and cell-to-matrix interactions mediate chemokine expression: an important component of the inflammatory lesion | Q41640106 | ||
| Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma | Q42513635 | ||
| Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha | Q42525456 | ||
| IL-4 upregulates tenascin synthesis in scleroderma and healthy skin fibroblasts | Q42527575 | ||
| Binding of interleukin-13 and interleukin-4 to the interleukin (IL)-4/IL-13 receptor of human synovial fibroblasts | Q42594768 | ||
| IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. | Q42818303 | ||
| Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression | Q43606201 | ||
| IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice | Q43803704 | ||
| Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality | Q46119457 | ||
| The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. | Q48032045 | ||
| Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. | Q50113265 | ||
| Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro | Q50232372 | ||
| Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts. | Q54797703 | ||
| Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts. | Q55473114 | ||
| Interleukin-4 and interferon-gamma discordantly regulate collagen biosynthesis by functionally distinct lung fibroblast subsets | Q71037699 | ||
| Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR) | Q71099789 | ||
| A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4 | Q71921204 | ||
| Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance | Q72732153 | ||
| Unusual interleukin-4 and -13 signaling in human normal and tumor lung fibroblasts | Q73322473 | ||
| Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis | Q73337805 | ||
| Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts | Q73478890 | ||
| The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway | Q73784963 | ||
| IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway | Q73993434 | ||
| Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain | Q74313373 | ||
| Histopathologic variability in usual and nonspecific interstitial pneumonias | Q77220427 | ||
| IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts | Q77492715 | ||
| Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat | Q77900005 | ||
| Immunoreactive interleukin 4 and interferon-gamma expression by type II alveolar epithelial cells in interstitial lung disease | Q77976545 | ||
| Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models | Q78103035 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | idiopathic interstitial pneumonia | Q1790424 |
| P304 | page(s) | 1989-2001 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia | |
| P478 | volume | 164 |
| Q36542274 | A review of current and novel therapies for idiopathic pulmonary fibrosis |
| Q24811760 | A role for MCP-1/CCR2 in interstitial lung disease in children. |
| Q42021416 | Aberrant innate immune sensing leads to the rapid progression of idiopathic pulmonary fibrosis |
| Q37098588 | Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis |
| Q58710919 | CCR10+ epithelial cells from idiopathic pulmonary fibrosis lungs drive remodeling |
| Q82194753 | Decoy receptor springs to life and eases fibrosis |
| Q39629411 | Deficient repair response of IPF fibroblasts in a co-culture model of epithelial injury and repair |
| Q24678621 | Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath |
| Q42876669 | Genome-wide transcriptional response during the development of bleomycin-induced pulmonary fibrosis in sprague-dawley rats |
| Q38010706 | IL-13 Signaling in Liver Fibrogenesis |
| Q35995705 | IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice |
| Q36440438 | Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy |
| Q41855310 | Mesenchymal cell survival in airway and interstitial pulmonary fibrosis |
| Q42830623 | Modulation of pulmonary fibrosis by IL-13Rα2. |
| Q33856238 | Protein kinase D is increased and activated in lung epithelial cells and macrophages in idiopathic pulmonary fibrosis |
| Q37644559 | Role of host genetics in fibrosis. |
| Q36617133 | Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases |
| Q38177817 | STAT6 and lung inflammation |
| Q38731737 | Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma |
| Q28748540 | Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages |
| Q55543508 | TRAIL-Dependent Resolution of Pulmonary Fibrosis. |
| Q92239480 | Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis |
| Q33799732 | Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. |
| Q42145272 | Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change |
| Q35691571 | Therapeutic targeting of CC ligand 21 or CC chemokine receptor 7 abrogates pulmonary fibrosis induced by the adoptive transfer of human pulmonary fibroblasts to immunodeficient mice |
| Q92890405 | Transcriptional regulation of the IL-13Rα2 gene in human lung fibroblasts |
| Q55241957 | Type 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis. |
| Q40074887 | Type 2 immunity in tissue repair and fibrosis |
Search more.